Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 8/10

vs
industry
vs
history
Cash to Debt No Debt
REPR's Cash to Debt is ranked higher than
91% of the 181 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.41 vs. REPR: No Debt )
Ranked among companies with meaningful Cash to Debt only.
REPR' s 10-Year Cash to Debt Range
Min: 0.04  Med: 0.51 Max: No Debt
Current: No Debt
Equity to Asset 0.86
REPR's Equity to Asset is ranked higher than
88% of the 169 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.59 vs. REPR: 0.86 )
Ranked among companies with meaningful Equity to Asset only.
REPR' s 10-Year Equity to Asset Range
Min: -0.62  Med: 0.36 Max: 0.86
Current: 0.86
-0.62
0.86
Interest Coverage 1147.00
REPR's Interest Coverage is ranked higher than
62% of the 104 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 38.48 vs. REPR: 1147.00 )
Ranked among companies with meaningful Interest Coverage only.
REPR' s 10-Year Interest Coverage Range
Min: 0.97  Med: 35.56 Max: 1147
Current: 1147
0.97
1147
F-Score: 6
Z-Score: 12.82
M-Score: -1.79
WACC vs ROIC
6.41%
23.61%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 10.20
REPR's Operating margin (%) is ranked higher than
61% of the 178 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.07 vs. REPR: 10.20 )
Ranked among companies with meaningful Operating margin (%) only.
REPR' s 10-Year Operating margin (%) Range
Min: -23.01  Med: 3.50 Max: 24.28
Current: 10.2
-23.01
24.28
Net-margin (%) 6.70
REPR's Net-margin (%) is ranked higher than
59% of the 178 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.54 vs. REPR: 6.70 )
Ranked among companies with meaningful Net-margin (%) only.
REPR' s 10-Year Net-margin (%) Range
Min: -25.71  Med: 3.31 Max: 29.98
Current: 6.7
-25.71
29.98
ROE (%) 13.10
REPR's ROE (%) is ranked higher than
72% of the 174 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.64 vs. REPR: 13.10 )
Ranked among companies with meaningful ROE (%) only.
REPR' s 10-Year ROE (%) Range
Min: -134.67  Med: 16.54 Max: 644.38
Current: 13.1
-134.67
644.38
ROA (%) 10.87
REPR's ROA (%) is ranked higher than
83% of the 183 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.56 vs. REPR: 10.87 )
Ranked among companies with meaningful ROA (%) only.
REPR' s 10-Year ROA (%) Range
Min: -36.99  Med: -0.16 Max: 57.04
Current: 10.87
-36.99
57.04
ROC (Joel Greenblatt) (%) 30.50
REPR's ROC (Joel Greenblatt) (%) is ranked higher than
76% of the 180 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 11.56 vs. REPR: 30.50 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
REPR' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -80.76  Med: 30.91 Max: 95.45
Current: 30.5
-80.76
95.45
Revenue Growth (3Y)(%) 18.60
REPR's Revenue Growth (3Y)(%) is ranked higher than
90% of the 148 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.00 vs. REPR: 18.60 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
REPR' s 10-Year Revenue Growth (3Y)(%) Range
Min: -12.6  Med: 12.60 Max: 26
Current: 18.6
-12.6
26
» REPR's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Insider Trades

Latest Guru Trades with REPR

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 21.69
REPR's P/E(ttm) is ranked higher than
68% of the 108 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 30.60 vs. REPR: 21.69 )
Ranked among companies with meaningful P/E(ttm) only.
REPR' s 10-Year P/E(ttm) Range
Min: 2.45  Med: 12.81 Max: 40
Current: 21.69
2.45
40
PE(NRI) 20.50
REPR's PE(NRI) is ranked higher than
72% of the 110 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 28.50 vs. REPR: 20.50 )
Ranked among companies with meaningful PE(NRI) only.
REPR' s 10-Year PE(NRI) Range
Min: 2.7  Med: 12.25 Max: 35
Current: 20.5
2.7
35
P/B 2.29
REPR's P/B is ranked higher than
57% of the 171 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.86 vs. REPR: 2.29 )
Ranked among companies with meaningful P/B only.
REPR' s 10-Year P/B Range
Min: 1.04  Med: 2.48 Max: 28.8
Current: 2.29
1.04
28.8
P/S 1.30
REPR's P/S is ranked higher than
77% of the 186 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.69 vs. REPR: 1.30 )
Ranked among companies with meaningful P/S only.
REPR' s 10-Year P/S Range
Min: 0.42  Med: 1.32 Max: 3.67
Current: 1.3
0.42
3.67
POCF 19.50
REPR's POCF is ranked lower than
53% of the 111 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 19.68 vs. REPR: 19.50 )
Ranked among companies with meaningful POCF only.
REPR' s 10-Year POCF Range
Min: 3.73  Med: 10.50 Max: 28.8
Current: 19.5
3.73
28.8
EV-to-EBIT 12.10
REPR's EV-to-EBIT is ranked higher than
79% of the 117 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 21.23 vs. REPR: 12.10 )
Ranked among companies with meaningful EV-to-EBIT only.
REPR' s 10-Year EV-to-EBIT Range
Min: -125.6  Med: 6.50 Max: 2673
Current: 12.1
-125.6
2673
PEG 3.01
REPR's PEG is ranked lower than
52% of the 65 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.87 vs. REPR: 3.01 )
Ranked among companies with meaningful PEG only.
REPR' s 10-Year PEG Range
Min: 0.33  Med: 1.48 Max: 5.57
Current: 3.01
0.33
5.57
Shiller P/E 8.97
REPR's Shiller P/E is ranked higher than
96% of the 79 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 30.67 vs. REPR: 8.97 )
Ranked among companies with meaningful Shiller P/E only.
REPR' s 10-Year Shiller P/E Range
Min: 3.9  Med: 10.00 Max: 40.4
Current: 8.97
3.9
40.4
Current Ratio 8.54
REPR's Current Ratio is ranked higher than
93% of the 174 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.55 vs. REPR: 8.54 )
Ranked among companies with meaningful Current Ratio only.
REPR' s 10-Year Current Ratio Range
Min: 0.79  Med: 2.36 Max: 9.6
Current: 8.54
0.79
9.6
Quick Ratio 6.76
REPR's Quick Ratio is ranked higher than
94% of the 174 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.68 vs. REPR: 6.76 )
Ranked among companies with meaningful Quick Ratio only.
REPR' s 10-Year Quick Ratio Range
Min: 0.28  Med: 0.96 Max: 7.47
Current: 6.76
0.28
7.47
Days Inventory 97.45
REPR's Days Inventory is ranked higher than
69% of the 173 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 128.70 vs. REPR: 97.45 )
Ranked among companies with meaningful Days Inventory only.
REPR' s 10-Year Days Inventory Range
Min: 81.94  Med: 180.00 Max: 230.05
Current: 97.45
81.94
230.05
Days Sales Outstanding 52.71
REPR's Days Sales Outstanding is ranked higher than
68% of the 154 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 62.15 vs. REPR: 52.71 )
Ranked among companies with meaningful Days Sales Outstanding only.
REPR' s 10-Year Days Sales Outstanding Range
Min: 29.25  Med: 45.60 Max: 73.22
Current: 52.71
29.25
73.22

Valuation & Return

vs
industry
vs
history
Price/Net Cash 10.25
REPR's Price/Net Cash is ranked higher than
64% of the 44 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 12.20 vs. REPR: 10.25 )
Ranked among companies with meaningful Price/Net Cash only.
REPR' s 10-Year Price/Net Cash Range
Min: 7  Med: 10.00 Max: 16.8
Current: 10.25
7
16.8
Price/Net Current Asset Value 3.16
REPR's Price/Net Current Asset Value is ranked higher than
76% of the 109 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.67 vs. REPR: 3.16 )
Ranked among companies with meaningful Price/Net Current Asset Value only.
REPR' s 10-Year Price/Net Current Asset Value Range
Min: 1.75  Med: 3.08 Max: 33
Current: 3.16
1.75
33
Price/Tangible Book 2.56
REPR's Price/Tangible Book is ranked higher than
62% of the 151 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.27 vs. REPR: 2.56 )
Ranked among companies with meaningful Price/Tangible Book only.
REPR' s 10-Year Price/Tangible Book Range
Min: 1.5  Med: 3.15 Max: 11
Current: 2.56
1.5
11
Price/Projected FCF 1.36
REPR's Price/Projected FCF is ranked higher than
67% of the 90 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.76 vs. REPR: 1.36 )
Ranked among companies with meaningful Price/Projected FCF only.
REPR' s 10-Year Price/Projected FCF Range
Min: 0.68  Med: 1.20 Max: 8.4
Current: 1.36
0.68
8.4
Price/Median PS Value 1.03
REPR's Price/Median PS Value is ranked higher than
64% of the 163 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.24 vs. REPR: 1.03 )
Ranked among companies with meaningful Price/Median PS Value only.
REPR' s 10-Year Price/Median PS Value Range
Min: 0.27  Med: 0.96 Max: 1.67
Current: 1.03
0.27
1.67
Price/Graham Number 1.52
REPR's Price/Graham Number is ranked higher than
74% of the 86 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.46 vs. REPR: 1.52 )
Ranked among companies with meaningful Price/Graham Number only.
REPR' s 10-Year Price/Graham Number Range
Min: 0.84  Med: 1.14 Max: 4.71
Current: 1.52
0.84
4.71
Earnings Yield (Greenblatt) (%) 8.81
REPR's Earnings Yield (Greenblatt) (%) is ranked higher than
86% of the 179 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.80 vs. REPR: 8.81 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
REPR' s 10-Year Earnings Yield (Greenblatt) (%) Range
Min: 0.1  Med: 12.80 Max: 34.5
Current: 8.81
0.1
34.5
Forward Rate of Return (Yacktman) (%) 6.97
REPR's Forward Rate of Return (Yacktman) (%) is ranked lower than
62% of the 87 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 11.10 vs. REPR: 6.97 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
REPR' s 10-Year Forward Rate of Return (Yacktman) (%) Range
Min: -2.9  Med: 4.80 Max: 36.1
Current: 6.97
-2.9
36.1

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:WST, BAX, COV, TMO, COO » details
Repro-Med Systems Inc was incorporated in the State of New York in March of 1980. The Company designs, manufactures and markets proprietary medical devices mainly for emergency medical applications and ambulatory infusion therapy. These products are regulated by the FDA. Its development and marketing focus are concentrated on the RES-Q-VAC(R) and the FREEDOM60(R) products. The FREEDOM60 uses 'engine' to create a constant pressure drive system. FREEDOM60(R) uses rate-controlled tubing with standard slide clamp and luer-lock connector on the patient end. Proprietary technology Employed in the FREEDOM60 uses constant pressure to administer drugs. FREEDOM60 avoids an important problem faced by electronic pumps currently on the market which Employ constant flow mechanisms that result in potentially dangerous, high pressures placed on indwelling catheters or under the skin. The Freedom60 Syringe Infusion Pump is designed for ambulatory medication infusions. The Company also designed and manufactured the Freedom60-FM, an enhanced version of the Freedom60 which contains an electronic flow monitor system that provides occlusion and end of infusion alarm. The Freedom60 use for Primary Immune Deficiency by injecting immune globulin under the skin as a subcutaneous administration continued to increase usage during the past year. This method has provided patients with improved quality of life with much fewer unpleasant side effects over the traditional intravenous route. The RES-Q-VAC(R) Emergency Airway Suction System is a lightweight, portable, hand-operated suction device that removes fluids from a patient's airway by attaching the RES-Q-VAC(R) pump to various proprietary sterile and non-sterile single-use catheters sized for adult and pediatric suctioning. The Company has introduced new, updated features including the FSP filter, new pediatric connectors, new graduated canister, new adult catheters, and new convenient carry pouch. It is also available with a flexible, portable LED white light source, which is attached to the top of the canister system and provides illumination for the medical professional during nighttime or low light conditions. The Company offers its products directly to large national accounts and emergency medical device distributors, as well as to regional distributors in the hospital respiratory care market.

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK